Sign in

CIK 0001982708 · Non-accelerated filer<br>Emerging growth company

Anbio Biotechnology

Sign in to watch
Ticker
NNNN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
other
Phone
4916096247281
Business address
FRIEDRICH-EBERT-ANLAGE 49, FRANKFURT AM MAIN, Germany, 60308
  1. CERT Other Certification
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. CORRESP Other Correspondence Between Filers and SEC Staff
  4. 8-A12B Other Registration of Securities
  5. F-1/A Offering Registration Statement for Certain Foreign Private Issuers
  6. F-1/A Offering Registration Statement for Certain Foreign Private Issuers
  7. FWP Offering Free Writing Prospectus
  8. F-1/A Offering Registration Statement for Certain Foreign Private Issuers
  9. F-1 Offering Registration Statement for Certain Foreign Private Issuers
  10. DRSLTR Other Correspondence Related to Draft Registration Statement
  11. DRS/A Other Draft Registration Statement
  12. UPLOAD Other SEC-generated Letter
  13. DRS/A Other Draft Registration Statement
  14. DRSLTR Other Correspondence Related to Draft Registration Statement
  15. DRS/A Other Draft Registration Statement
  16. UPLOAD Other SEC-generated Letter
  17. DRS/A Other Draft Registration Statement
  18. DRSLTR Other Correspondence Related to Draft Registration Statement
  19. UPLOAD Other SEC-generated Letter
  20. DRS/A Other Draft Registration Statement

Page 2 of 3 · 43 filings